Reviewing Nexentis Technologies (NXTS) & Its Competitors

Nexentis Technologies (NASDAQ:NXTS – Get Free Report) is one of 896 publicly-traded companies in the “Pharmaceuticals” industry, but how does it contrast to its peers? We will compare Nexentis Technologies to related businesses based on the strength of its institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Insider & Institutional Ownership

61.2% of Nexentis Technologies shares are held by institutional investors. Comparatively, 32.5% of shares of all “Pharmaceuticals” companies are held by institutional investors. 6.5% of Nexentis Technologies shares are held by company insiders. Comparatively, 14.2% of shares of all “Pharmaceuticals” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings for Nexentis Technologies and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexentis Technologies 1 0 0 0 1.00
Nexentis Technologies Competitors 7782 13876 25773 1035 2.41

As a group, “Pharmaceuticals” companies have a potential upside of 25.77%. Given Nexentis Technologies’ peers stronger consensus rating and higher probable upside, analysts clearly believe Nexentis Technologies has less favorable growth aspects than its peers.

Profitability

This table compares Nexentis Technologies and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nexentis Technologies N/A -304.79% -178.91%
Nexentis Technologies Competitors -2,372.59% -220.82% -15.99%

Volatility and Risk

Nexentis Technologies has a beta of 1.95, indicating that its stock price is 95% more volatile than the S&P 500. Comparatively, Nexentis Technologies’ peers have a beta of -3.72, indicating that their average stock price is 472% less volatile than the S&P 500.

Valuation and Earnings

This table compares Nexentis Technologies and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Nexentis Technologies $210,000.00 -$4.00 million -0.01
Nexentis Technologies Competitors $3.52 billion $3.15 billion 550.65

Nexentis Technologies’ peers have higher revenue and earnings than Nexentis Technologies. Nexentis Technologies is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Nexentis Technologies peers beat Nexentis Technologies on 10 of the 13 factors compared.

About Nexentis Technologies

(Get Free Report)

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company’s products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. It also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.

Receive News & Ratings for Nexentis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexentis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.